Arthur Hiller

Arthur Hiller is a senior executive, consultant, and advisor with extensive experience in the life sciences industry.1 He currently serves as a Senior Advisor at Princeton Capital Advisors, a position he has held since February 2021.1

Professional Background

Arthur Hiller has a diverse background in biotech, pharmaceutical, and life sciences, with expertise in:

• Commercialization and growth strategy
• New technology identification and assessment
• Product launch, branding, and positioning
• Business development and partnership negotiation
• Merger and acquisition transactions
• Digital health technology strategy
• Fundraising and exit strategy

Career Highlights

• Chief Executive Officer at Amasa Therapeutics2
• Chief Business Officer at Nuritas
• Strategic Consultant through his company Hiller Life Sciences Strategies, LLC (since October 2014)1
• Chief Executive Officer at Heartscape Technologies (July 2006 - March 2010)1

Education

Arthur Hiller holds:

• Master of Science in Business Policy from Columbia Business School
• Bachelor of Science in Journalism from Northwestern University

Skills and Expertise

Throughout his career, Hiller has demonstrated:

• Strong commercial operations experience
• Exceptional written and oral communication skills
• Expertise in reimbursement strategy and market access
• Proficiency in assessing new technologies for potential impact

At Princeton Capital Advisors, Hiller contributes to the firm's focus on serving the specific needs of both large and mid-market biopharma companies on international M&A, licensing, and capital transactions.1